Daily, 3000 people die
from doubting chest pain 

RELF

empowers people 
to take life-saving decisions

 

ABOUT

Arts die Digitale Tablet

Ghent University Hospital developed an easy to use and validated device for self-detection of acute coronary occlusion in subjects with chest discomfort based on a proprietary 3- lead ECG system and algorithm. 

Self-recording with a RELF device is feasible for most patients with coronary artery disease. The sensitivity and specificity for automatic detection of the earliest phase of acute coronary artery occlusion support the concept of the RELF device for patient empowerment to reduce delay and increase survival without overloading emergency services.

PUBLICATIONS

Lancet Digital Health

VOLUME 1, ISSUE 2, PE90-E99, JUNE 01, 2019

BioVox

URL

DECEMBER 18, 2017

Liberale Mutualiteit

Liever Thuis Lm, NR 4 / 2019

Journal of Electrocardiology

VOLUME 49, P192-201, 2016

ESC Congress 2019 &

World Congress of Cardiology

31 AUGUST – 4 SEPTEMBER 2019, PARIS - FRANCE

lancet
lancet

press to zoom
biovox
biovox

press to zoom
elec
elec

press to zoom
lancet
lancet

press to zoom
1/5
 
 

VIDEOS